Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2007

Open Access 01-09-2007 | Research

A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study

Authors: Shih-Jen Hwang, Qiong Yang, James B Meigs, Elizabeth N Pearce, Caroline S Fox

Published in: BMC Medical Genetics | Special Issue 1/2007

Login to get access

Abstract

Background

Glomerular filtration rate (GFR) and urinary albumin excretion (UAE) are markers of kidney function that are known to be heritable. Many endocrine conditions have strong familial components. We tested for association between the Affymetrix GeneChip Human Mapping 100K single nucleotide polymorphism (SNP) set and measures of kidney function and endocrine traits.

Methods

Genotype information on the Affymetrix GeneChip Human Mapping 100K SNP set was available on 1345 participants. Serum creatinine and cystatin-C (cysC; n = 981) were measured at the seventh examination cycle (1998–2001); GFR (n = 1010) was estimated via the Modification of Diet in Renal Disease (MDRD) equation; UAE was measured on spot urine samples during the sixth examination cycle (1995–1998) and was indexed to urinary creatinine (n = 822). Thyroid stimulating hormone (TSH) was measured at the third and fourth examination cycles (1981–1984; 1984–1987) and mean value of the measurements were used (n = 810). Age-sex-adjusted and multivariable-adjusted residuals for these measurements were used in association with genotype data using generalized estimating equations (GEE) and family-based association tests (FBAT) models. We presented the results for association tests using additive allele model. We evaluated associations with 70,987 SNPs on autosomes with minor allele frequencies of at least 0.10, Hardy-Weinberg Equilibrium p-value ≥ 0.001, and call rates of at least 80%.

Results

The top SNPs associated with these traits using the GEE method were rs2839235 with GFR (p-value 1.6*10-05), rs1158167 with cysC (p-value 8.5*10-09), rs1712790 with UAE (p-value 1.9*10-06), and rs6977660 with TSH (p-value 3.7*10-06), respectively. The top SNPs associated with these traits using the FBAT method were rs6434804 with GFR(p-value 2.4*10-5), rs563754 with cysC (p-value 4.7*10-5), rs1243400 with UAE (p-value 4.8*10-6), and rs4128956 with TSH (p-value 3.6*10-5), respectively. Detailed association test results can be found at http://​www.​ncbi.​nlm.​nih.​gov/​projects/​gap/​cgi-bin/​study.​cgi?​id=​phs000007. Four SNPs in or near the CST3 gene were highly associated with cysC levels (p-value 8.5*10-09 to 0.007).

Conclusion

Kidney function traits and TSH are associated with SNPs on the Affymetrix GeneChip Human Mapping 100K SNP set. These data will serve as a valuable resource for replication as more SNPs associated with kidney function and endocrine traits are identified.
Literature
1.
Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003, 41: 1-12. 10.1053/ajkd.2003.50007.CrossRefPubMed
2.
Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003, 41: 47-55. 10.1016/S0735-1097(02)02663-3.CrossRefPubMed
3.
Manjunath G, Tighiouart H, Coresh J, MacLeod B, Salem DN, Griffith JL, Levey AS, Sarnak MJ: Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003, 63: 1121-1129. 10.1046/j.1523-1755.2003.00838.x.CrossRefPubMed
4.
Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med. 2001, 134: 629-636.CrossRefPubMed
5.
Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol. 2003, 41: 1364-1372. 10.1016/S0735-1097(03)00163-3.CrossRefPubMed
6.
O'Hare AM, Vittinghoff E, Hsia J, Shlipak MG: Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the heart and estrogen/progestin replacement study (HERS). J Am Soc Nephrol. 2004, 15: 1046-1051. 10.1097/01.ASN.0000119574.27772.FD.CrossRefPubMed
7.
Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004, 15: 1307-1315. 10.1097/01.ASN.0000123691.46138.E2.CrossRefPubMed
8.
Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999, 56: 2214-2219. 10.1046/j.1523-1755.1999.00773.x.CrossRefPubMed
9.
Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA. 2004, 291: 844-850. 10.1001/jama.291.7.844.CrossRefPubMed
10.
Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J: The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004, 140: 9-17.CrossRefPubMed
11.
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR: Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003, 63: 225-232. 10.1046/j.1523-1755.2003.00712.x.CrossRefPubMed
12.
Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med. 1996, 335: 1636-1642. 10.1056/NEJM199611283352203.CrossRefPubMed
13.
Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med. 1995, 123: 754-762.CrossRefPubMed
14.
Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med. 1996, 334: 939-945. 10.1056/NEJM199604113341502.CrossRefPubMed
15.
Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002, 61: 2165-2175. 10.1046/j.1523-1755.2002.00356.x.CrossRefPubMed
16.
Lei HH, Perneger TV, Klag MJ, Whelton PK, Coresh J: Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol. 1998, 9: 1270-1276.PubMed
17.
DeWan AT, Arnett DK, Atwood LD, Province MA, Lewis CE, Hunt SC, Eckfeldt J: A genome scan for renal function among hypertensives: the HyperGEN study. Am J Hum Genet. 2001, 68: 136-144. 10.1086/316927.PubMedCentralCrossRefPubMed
18.
Cohn DH, Shohat T, Yahav M, Ilan T, Rechavi G, King L, Shohat M: A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. Am J Hum Genet. 2000, 67: 647-651. 10.1086/303051.PubMedCentralCrossRefPubMed
19.
Freedman BI, Rich SS, Yu H, Roh BH, Bowden DW: Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int. 2002, 62: 770-774. 10.1046/j.1523-1755.2002.00534.x.CrossRefPubMed
20.
Hunt SC, Hasstedt SJ, Coon H, Camp NJ, Cawthon RM, Wu LL, Hopkins PN: Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat. Kidney Int. 2002, 62: 1143-1148. 10.1111/j.1523-1755.2002.kid557.x.CrossRefPubMed
21.
Hunt SC, Coon H, Hasstedt SJ, Cawthon RM, Camp NJ, Wu LL, Hopkins PN: Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees. Am J Hypertens. 2004, 17: 511-515. 10.1016/j.amjhyper.2004.02.019.CrossRefPubMed
22.
Placha G, Poznik GD, Dunn J, Smiles A, Krolewski B, Glew T, Puppala S, Schneider J, Rogus JJ, Rich SS, Duggirala R, Warram JH, Krolewski AS: A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes. 2006, 55: 3358-3365. 10.2337/db06-0781.CrossRefPubMed
23.
Fox CS, Yang Q, Cupples LA, Guo CY, Larson MG, Leip EP, Wilson PW, Levy D: Genomewide Linkage Analysis to Serum Creatinine, GFR, and Creatinine Clearance in a Community-Based Population: The Framingham Heart Study. J Am Soc Nephrol. 2004, 15: 2457-2461. 10.1097/01.ASN.0000135972.13396.6F.CrossRefPubMed
24.
Pontiroli AE, Monti LD, Pizzini A, Piatti P: Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes. Diabetes Care. 2000, 23: 1359-1364. 10.2337/diacare.23.9.1359.CrossRefPubMed
25.
Forsblom CM, Kanninen T, Lehtovirta M, Saloranta C, Groop LC: Heritability of albumin excretion rate in families of patients with Type II diabetes. Diabetologia. 1999, 42: 1359-1366. 10.1007/s001250051450.CrossRefPubMed
26.
Freedman BI, Beck SR, Rich SS, Heiss G, Lewis CE, Turner S, Province MA, Schwander KL, Arnett DK, Mellen BG: A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension. 2003, 42: 291-296. 10.1161/01.HYP.0000087890.33245.41.CrossRefPubMed
27.
Iyengar SK, Fox KA, Schachere M, Manzoor F, Slaughter ME, Covic AM, Orloff SM, Hayden PS, Olson JM, Schelling JR, Sedor JR: Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol. 2003, 14: S195-S201. 10.1097/01.ASN.0000070078.66465.55.CrossRefPubMed
28.
Chung KW, Ferrell RE, Ellis D, Barmada M, Moritz M, Finegold DN, Jaffe R, Vats A: African American hypertensive nephropathy maps to a new locus on chromosome 9q31–q32. Am J Hum Genet. 2003, 73: 420-429. 10.1086/377184.PubMedCentralCrossRefPubMed
29.
Fox CS, Yang Q, Guo CY, Cupples LA, Wilson PW, Levy D, Meigs JB: Genome-wide linkage analysis to urinary microalbuminuria in a community-based sample: The Framingham Heart Study. Kidney Int. 2005, 67: 70-74. 10.1111/j.1523-1755.2005.00056.x.CrossRefPubMed
30.
Hall R, Stanbury JB: Familial studies of autoimmune thyroiditis. Clin Exp Immunol. 1967, 2 (Suppl-25):
31.
Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF: Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab. 1999, 84: 4656-4664. 10.1210/jc.84.12.4656.PubMed
32.
Samollow PB, Perez G, Kammerer CM, Finegold D, Zwartjes PW, Havill LM, Comuzzie AG, Mahaney MC, Goring HH, Blangero J, Foley TP, Barmada MM: Genetic and environmental influences on thyroid hormone variation in Mexican Americans. J Clin Endocrinol Metab. 2004, 89: 3276-3284. 10.1210/jc.2003-031706.CrossRefPubMed
33.
Hansen PS, Brix TH, Sorensen TI, Kyvik KO, Hegedus L: Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J Clin Endocrinol Metab. 2004, 89: 1181-1187. 10.1210/jc.2003-031641.CrossRefPubMed
34.
Meikle AW, Stringham JD, Woodward MG, Nelson JC: Hereditary and environmental influences on the variation of thyroid hormones in normal male twins. J Clin Endocrinol Metab. 1988, 66: 588-592.CrossRefPubMed
35.
Vaidya B, Imrie H, Perros P, Young ET, Kelly WF, Carr D, Large DM, Toft AD, Kendall-Taylor P, Pearce SH: Evidence for a new Graves disease susceptibility locus at chromosome 18q21. Am J Hum Genet. 2000, 66: 1710-1714. 10.1086/302908.PubMedCentralCrossRefPubMed
36.
Hadj KH, Rebai A, Kaffel N, Abid M, Ayadi H: Evidence for linkage and association between autoimmune thyroid diseases and the 18q12–q21 region in a large Tunisian family. Int J Immunogenet. 2006, 33: 25-32. 10.1111/j.1744-313X.2005.00554.x.CrossRef
37.
Cupples LA, Arruda H, Benjamin EJ, D'Agostino RB, Demissie S, DeStefano AL, Dupuis J, Falls K, Fox CS, Gottlieb DJ, Govindaraju DR, Guo CY, Hwang SJ, Kathiresan S, Kiel DP, Larson MG, Laramie JM, Levy D, Lunetta KL, Mailman MD, Manning AK, Meigs JB, Murabito JM, Newton-Cheh C, O'Connor GT, O'Donnell CJ, Pandey MA, Qiong Y, Seshadri S, Vasan RS, Wang ZY, Wolf PA, Atwood LD: The Framingham Heart Study 100K SNP genome-wide association study resource: Overview of 17 phenotype working group reports. BMC Med Genet. 2007, 8 (Suppl 1): S1-PubMedCentralCrossRefPubMed
38.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.CrossRefPubMed
39.
K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002, 39: S1-246. 10.1053/ajkd.2002.32799.
40.
Nathan DM, Rosenbaum C, Protasowicki VD: Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care. 1987, 10: 414-418. 10.2337/diacare.10.4.414.CrossRefPubMed
41.
Bakker AJ: Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care. 1999, 22: 307-313. 10.2337/diacare.22.2.307.CrossRefPubMed
42.
Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS: Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med. 2006, 166: 1884-1891. 10.1001/archinte.166.17.1884.CrossRefPubMed
43.
Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PW, Felson DT: Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med. 2000, 133: 951-963.CrossRefPubMed
44.
Arnlov J, Pencina MJ, Amin S, Nam BH, Benjamin EJ, Murabito JM, Wang TJ, Knapp PE, D'Agostino RB, Bhasin S, Vasan RS: Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med. 2006, 145: 176-184.CrossRefPubMed
45.
Yang Q, Guo CY, Cupples LA, Levy D, Wilson PW, Fox CS: Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism. 2005, 54: 1435-1441. 10.1016/j.metabol.2005.05.007.CrossRefPubMed
46.
Camp TM, Smiley LM, Hayden MR, Tyagi SC: Mechanism of matrix accumulation and glomerulosclerosis in spontaneously hypertensive rats. J Hypertens. 2003, 21: 1719-1727. 10.1097/00004872-200309000-00022.CrossRefPubMed
47.
Ginsberg J, Labedz T, Brindley DN: Phosphorylation of Heat Shock Protein-90 by TSH in FRTL-5 Thyroid Cells. Thyroid. 2006, 16: 737-742. 10.1089/thy.2006.16.737.CrossRefPubMed
48.
Kanaya AM, Harris F, Volpato S, Perez-Stable EJ, Harris T, Bauer DC: Association between thyroid dysfunction and total cholesterol level in an older biracial population: the health, aging and body composition study. Arch Intern Med. 2002, 162: 773-779. 10.1001/archinte.162.7.773.CrossRefPubMed
49.
Eriksson P, Deguchi H, Samnegard A, Lundman P, Boquist S, Tornvall P, Ericsson CG, Bergstrand L, Hansson LO, Ye S, Hamsten A: Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol. 2004, 24: 551-557. 10.1161/01.ATV.0000117180.57731.36.CrossRefPubMed
50.
Hsu CC, Kao WH, Coresh J, Pankow JS, Marsh-Manzi J, Boerwinkle E, Bray MS: Apolipoprotein E and progression of chronic kidney disease. JAMA. 2005, 293: 2892-2899. 10.1001/jama.293.23.2892.CrossRefPubMed
51.
Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG: Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004, 141: 929-937.CrossRefPubMed
52.
Rule AD, Bergstralh EJ, Slezak JM, Bergert J, Larson TS: Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int. 2006, 69: 399-405. 10.1038/sj.ki.5000073.CrossRefPubMed
53.
Hoek FJ, Kemperman FA, Krediet RT: A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003, 18: 2024-2031. 10.1093/ndt/gfg349.CrossRefPubMed
54.
Grubb A, Bjork J, Lindstrom V, Sterner G, Bondesson P, Nyman U: A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest. 2005, 65: 153-162. 10.1080/00365510510013596.CrossRefPubMed
55.
Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005, 352: 2049-2060. 10.1056/NEJMoa043161.CrossRefPubMed
56.
Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, Satterfield S, Cummings SR, Newman AB, Fried LF: Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2006, 17: 254-261. 10.1681/ASN.2005050545.CrossRefPubMed
57.
Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB: Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol. 2005, 16: 3728-3735. 10.1681/ASN.2005040384.CrossRefPubMed
58.
O'Hare AM, Newman AB, Katz R, Fried LF, Stehman-Breen CO, Seliger SL, Siscovick DS, Shlipak MG: Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study. Arch Intern Med. 2005, 165: 2666-2670. 10.1001/archinte.165.22.2666.CrossRefPubMed
59.
Shlipak MG, Katz R, Fried LF, Jenny NS, Stehman-Breen CO, Newman AB, Siscovick D, Psaty BM, Sarnak MJ: Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol. 2005, 45: 268-271. 10.1016/j.jacc.2004.09.061.CrossRefPubMed
Metadata
Title
A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study
Authors
Shih-Jen Hwang
Qiong Yang
James B Meigs
Elizabeth N Pearce
Caroline S Fox
Publication date
01-09-2007
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue Special Issue 1/2007
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-8-S1-S10

Other articles of this Special Issue 1/2007

BMC Medical Genetics 1/2007 Go to the issue

Introduction

The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports

Research

Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study

Research

Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study

Research

Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study

Research

Genome-wide association with select biomarker traits in the Framingham Heart Study

Research

Genome-wide association with diabetes-related traits in the Framingham Heart Study